Healthcare research multiple myeloma - analysis in patient referring physician and participation satisfaction concerning the interdisciplinary CCF MM-tumorboard.
- Conditions
- C90.0Multiple myeloma
- Registration Number
- DRKS00008573
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with multiple myeloma
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the satisfaction of MM-Patients with standardized questionnaires at the moment of indication of therapy.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the key molecular mechanisms of multiple myeloma addressed in DRKS00008573 interdisciplinary CCF MM-tumorboard analysis?
How does the interdisciplinary CCF MM-tumorboard approach compare to standard-of-care treatment protocols for C90.0 multiple myeloma patients?
What biomarkers are used to select patients for the DRKS00008573 observational study on multiple myeloma tumorboard outcomes?
What adverse events are associated with interdisciplinary tumorboard-guided treatment strategies in multiple myeloma clinical practice?
How do combination therapies involving CCF MM-tumorboard recommendations compare to monotherapies in multiple myeloma treatment efficacy?